• NAMRATA KHAIRNAR Department of Pharmaceutics, Gokhale Education Society’s Sir Dr. M. S. Gosavi College of Pharmaceutical Education and Research, Nashik 422005, Maharashtra, India
  • PRASHANT PINGALE Department of Pharmaceutics, Gokhale Education Society’s Sir Dr. M. S. Gosavi College of Pharmaceutical Education and Research, Nashik 422005, Maharashtra, India
  • SUNIL AMRUTKAR Department of Pharmaceutical Chemistry, Gokhale Education Society’s Sir Dr. M. S. Gosavi College of Pharmaceutical Education and Research, Nashik 422005, Maharashtra, India



Micronutrients, Heart, Nutrition, Vitamins


Heart disease is a common occurrence in older patients in the civilized culture, and the rate is predicted to rise as the software advances. Patients with heart disease should be intended to eat a salt-free diet to lose adiposity. Diet is also critical for heart disease patients; those with nutrition deficits have a low deep prognosis. A growing body of research indicates a correlation between heart disease and a lack of micronutrients. Repairable heart disease has been linked to thiamine and selenium deficiency. Micronutrients and heart disease may, nevertheless, have a more moderate association, according to recent research. This article looks at studies that looked at micronutrient consumption, supplement effectiveness, and micronutrient ingestion in heart disease patients, with an emphasis on retinol, ascorbic acid, a fat-soluble vitamin, vitamin B1, other B vitamins, cholecalciferol, folate, iron, and copper. Because aging is the leading cause of coronary heart disease, treatments intended to reduce down the aging process or improving life expectancy are distinctly different from their standards for the treatment of coronary heart disease. Altering risky life decisions which might relate to aging and coronary heart diseases, such as nicotine usage, obesity, and unique lifestyles, is increasingly become part of the quality of practice.


Download data is not yet available.


Buttar HS, Li T, Ravi N. Prevention of cardiovascular diseases: role of exercise, dietary interventions, obesity and smoking cessation. Exp Clin Cardiol. 2005;10(4):229-49. PMID 19641674.

Nakhaee S, Ghasemi S, Karimzadeh K, Zamani N, Alinejad-Mofrad S, Mehrpour O. The effects of opium on the cardiovascular system: a review of side effects, uses, and potential mechanisms. Subst Abuse Treat Prev Policy. 2020 Dec;15(1):30. doi: 10.1186/s13011-020-00272-8, PMID 32303254.

Anand SS, Hawkes C, De Souza RJ, Mente A, Dehghan M, Nugent R, Zulyniak MA, Weis T, Bernstein AM, Krauss RM, Kromhout D, Jenkins DJA, Malik V, Martinez-Gonzalez MA, Mozaffarian D, Yusuf S, Willett WC, Popkin BM. Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System: A Report From the Workshop Convened by the World Heart Federation. J Am Coll Cardiol. 2015 Oct 6;66(14):1590-614. doi: 10.1016/j.jacc.2015.07.050, PMID 26429085.

Riegel B, Moser DK, Buck HG, Dickson VV, Dunbar SB, Lee CS, Lennie TA, Lindenfeld J, Mitchell JE, Treat‐Jacobson DJ, Webber DE, American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Peripheral Vascular Disease; and Council on Quality of Care and Outcomes Research. Self-care for the prevention and management of cardiovascular disease and stroke: A scientific statement for healthcare professionals from the American Heart Association. J Am Heart Assoc. 2017 Aug 31;6(9):e006997. doi: 10.1161/JAHA.117.006997, PMID 28860232.

Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016 Jan 12;133(2):187-225. doi: 10.1161/CIRCULATIONAHA.115.018585, PMID 26746178.

Jensen S, Yates B, Lyden E, Hanson C. Micronutrient intake of participants in a ”partners together in health” cardiac rehab intervention. J Acad Nutr Diet. 2017 Sep 1;117(9):A59. doi: 10.1016/j.jand.2017.06.178.

Bonucchi J, Hassan I, Policeni B, Kaboli P. Thyrotoxicosis associated Wernicke’s encephalopathy. J Gen Intern Med. 2008 Jan 1;23(1):106-9. doi: 10.1007/s11606-007-0438-3, PMID 18026802.

Milne I. Who was James Lind, and what exactly did he achieve. J R Soc Med. 2012 Dec;105(12):503-8. doi: 10.1258/jrsm.2012.12k090, PMID 23288083.

Zhang R, Naughton DP. Vitamin D in health and disease: current perspectives. Nutr J. 2010 Dec;9:65. doi: 10.1186/1475-2891-9-65, PMID 21143872.

Izzo M, Carrizzo A, Izzo C, Cappello E, Cecere D, Ciccarelli M, Iannece P, Damato A, Vecchione C, Pompeo F. Vitamin D: not just bone metabolism but a key player in cardiovascular diseases. Life (Basel). 2021 May;11(5):452. doi: 10.3390/life11050452, PMID 34070202.

Martens PJ, Gysemans C, Verstuyf A, Mathieu AC. Vitamin D’s effect on immune function. Nutrients. 2020 May;12(5):1248. doi: 10.3390/nu12051248, PMID 32353972.

Bittker SS. Elevated levels of 1, 25-dihydroxyvitamin D in plasma as a missing risk factor for celiac disease. Clin Exp Gastroenterol. 2020;13:1-15. doi: 10.2147/CEG.S222353, PMID 32021373.

Anderson PH, May BK, Morris HA. Vitamin D metabolism: new concepts and clinical implications. Clin Biochem Rev. 2003 Feb;24(1):13-26. PMID 18650961.

Lugg ST, Howells PA, Thickett DR. Optimal vitamin D supplementation levels for cardiovascular disease protection. Dis Markers. 2015 Sep 8;2015:864370. doi: 10.1155/2015/864370, PMID 26435569.

Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D’Agostino RB, Wolf M, Vasan RS. Vitamin D Deficiency and Risk of Cardiovascular Disease. Circulation. 2008;117(4):503-11. doi: 10.1161/CIRCULATIONAHA.107.706127.

Sosa Henríquez M, Gómez de Tejada Romero MJ. Cholecalciferol or calcifediol in the management of vitamin D deficiency. Nutrients. 2020 Jun;12(6):1617. doi: 10.3390/nu12061617, PMID 32486496.

DiNicolantonio JJ, Niazi AK, Lavie CJ, O’Keefe JH, Ventura HO. Thiamine supplementation for the treatment of heart failure: a review of the literature. Congest Heart Fail. 2013 Jul;19(4):214-22. doi: 10.1111/chf.12037, PMID 23910704.

Helali J, Park S, Ziaeian B, Han JK, Lankarani-Fard A. Thiamine and heart failure: challenging cases of modern-day cardiac beriberi. Mayo Clin Proc Innov Qual Outcomes. 2019 Jun 1;3(2):221-5. doi: 10.1016/j.mayocpiqo.2019.03.003, PMID 31193878.

Kibirige D, Mwebaze R. Vitamin B12 deficiency among patients with diabetes mellitus: is routine screening and supplementation justified? J Diabetes Metab Disord. 2013 Dec;12(1):17. doi: 10.1186/2251-6581-12-17, PMID 23651730.

Moretti R, Peinkhofer C. B vitaminS and fatty acids: what do they share with small vessel disease-related dementia? Int J Mol Sci. 2019 Jan;20(22):5797. doi: 10.3390/ijms20225797, PMID 31752183.

Saini R. Coenzyme Q10:The essential nutrient. J Pharm Bioallied Sci. 2011 Jul 1;3(3):466-7. doi: 10.4103/0975-7406.84471, PMID 21966175.

Zozina VI, Covantev S, Goroshko OA, Krasnykh LM, Kukes VG. Coenzyme Q10 in cardiovascular and metabolic diseases: current state of the problem. Curr Cardiol Rev. 2018 Aug 1;14(3):164-74. doi: 10.2174/1573403X14666180416115428, PMID 29663894.

Belardinelli R, Muçaj A, Lacalaprice F, Solenghi M, Seddaiu G, Principi F, Tiano L, Littarru GP. Coenzyme Q10 and exercise training in chronic heart failure. Eur Heart J. 2006 Nov 1;27(22):2675-81. doi: 10.1093/eurheartj/ehl158, PMID 16882678.

Fotino AD, Thompson-Paul AM, Bazzano LA. Effect of coenzyme Q₁₀ supplementation on heart failure: a meta-analysis. Am J Clin Nutr. 2013 Feb 1;97(2):268-75. doi: 10.3945/ajcn.112.040741, PMID 23221577.

Di Lorenzo A, Iannuzzo G, Parlato A, Cuomo G, Testa C, Coppola M, D’Ambrosio G, Oliviero DA, Sarullo S, Vitale G, Nugara C, Sarullo FM, Giallauria F. Clinical evidence for Q10 coenzyme supplementation in heart failure: from energetics to functional improvement. J Clin Med. 2020 May;9(5):1266. doi: 10.3390/jcm9051266, PMID 32349341.

Lei L, Liu Y. Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials. BMC Cardiovasc Disord. 2017 Dec;17(1):196. doi: 10.1186/s12872-017-0628-9, PMID 28738783.

Li Y, Fitzgibbons TP, McManus DD, Goddeau Jr RP, Silver B, Henninger N. Left ventricular ejection fraction and clinically defined heart failure to predict 90-day functional outcome after ischemic stroke. J Stroke Cerebrovasc Dis. 2019 Feb 1;28(2):371-80. doi: 10.1016/j.jstrokecerebrovasdis.2018.10.002, PMID 30396839.

Patel J, Sandhu A, Parizo J, Moayedi Y, Fonarow GC, Heidenreich PA. Validity of performance and outcome measures for heart failure. Circ Heart Fail. 2018 Sep;11(9):e005035. doi: 10.1161/CIRCHEARTFAILURE.118.005035, PMID 30354367.

Savarese G, Lund LH. Global Public Health Burden of Heart Failure. Card Fail Rev. 2017;3(1):7-11. doi: 10.15420/cfr.2016:25:2. PMID 28785469.

Bagheri B, Akbari N, Tabiban S, Habibi V, Mokhberi V. Serum level of copper in patients with coronary artery disease. Niger Med J. 2015 Jan;56(1):39-42. doi: 10.4103/0300-1652.149169, PMID 25657492.

Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G. Vitamin D deficiency and risk of cardiovascular diseases: a narrative review. Clin Hypertens. 2018 Dec;24:9. doi: 10.1186/s40885-018-0094-4, PMID 29977597.

Kurutas EB. The importance of antioxidants which play a role in cellular response against oxidative/nitrosative stress: current state. Nutr J. 2016 Dec;15(1):71. doi: 10.1186/s12937-016-0186-5, PMID 27456681.

Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q. Role of carnitine in disease. Nutrition and mMetabolism. 2010 Dec; 7:1-4.

Sada H, Kato A, Sumimoto R, Ohmori H, Ohdan H. Effects of L-carnitine supplementation on nutritional, immunological, and cardiac parameters in hemodialysis patients: a pilot study. Renal Replacement Therapy. 2015 Dec; 1:1-8.

Song X, Qu H, Yang Z, Rong J, Cai W, Zhou H. Efficacy and safety of L-carnitine treatment for chronic heart failure: a meta-analysis of randomized controlled trials. BioMed research international. 2017 Apr 13;2017:6274854. doi: 10.1155/2017/6274854, PMID 28497060.

Fielding R, Riede L, Lugo JP, Bellamine A. L-carnitine supplementation in recovery after exercise. Nutrients. 2018 Mar; 10(3):349. doi: 10.3390/nu10030349, PMID 29534031.

Chen GC, Lu DB, Pang Z, Liu QF. Vitamin C intake, circulating vitamin C and risk of stroke: a meta‐analysis of prospective studies. Journal of the American Heart Association. 2013 Nov 27;2(6):e000329. doi: 10.1161/JAHA.113.000329, PMID 24284213.

Juraschek SP, Guallar E, Appel LJ, Miller III ER. Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. The American journalJ of cClinical nNutrition. 2012 May 1;95(5):1079-88. doi: 10.3945/ajcn.111.027995, PMID 22492364.

Tan BL, Norhaizan ME, Liew WP, Sulaiman Rahman H. Antioxidant and oxidative stress: a mutual interplay in age-related diseases. Frontiers in pPharmacology. 2018 Oct 16;9:1162. doi: 10.3389/fphar.2018.01162, PMID 30405405.

Tinelli C, Di Pino A, Ficulle E, Marcelli S, Feligioni M. Hyperhomocysteinemia as a risk factor and potential nutraceutical target for certain pathologies. Frontiers in nNutrition. 2019 Apr 24;6:49. doi: 10.3389/fnut.2019.00049, PMID 31069230.

Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr. J. 2015;14:6.



How to Cite

KHAIRNAR, N., P. PINGALE, and S. AMRUTKAR. “ROLE OF MICRONUTRIENTS IN HEART DISEASES”. International Journal of Current Pharmaceutical Research, vol. 13, no. 5, Sept. 2021, pp. 1-5, doi:10.22159/ijcpr.2021v13i5.1880.



Review Article(s)